Rona, a portfolio company of Sycamore Partners, has acquired All-Fab Group (AFG), a provider of building products across Western Canada.

Earlier this week, a report emerged that Walgreens is considering a sale to private equity firm Sycamore Partners. If the speculation turns into reality, the deal could put the iconic drugstore ...

Jay Asser is the CEO editor for HealthLeaders. Walgreens is considering a sale to private equity firm Sycamore Partners after its market value plummeted from $100 billion in 2015 to around $7.5 ...

The potential deal, first reported yesterday by the Wall Street Journal, would have Deerfield-based Walgreens sell itself to Sycamore Partners, a private-equity firm usually investing in consumer ...

Walgreens Boots Alliance to report Q1 FY2025 results as analysts project $0.38 EPS on $37.3 billion revenue. Key focus ...

Walgreens is considering selling itself to a private equity firm, in a deal that could be done early next year. Walgreens is in talks with Sycamore Partners to take the publicly listed company ...

A spokesperson for Sycamore declined to comment ... businesses countering the U.S. retail pharmacy decline. In 2019, private equity firm KKR sought to buy out Walgreens when the company was ...

Walgreens could be sold to private-equity firm Sycamore Partners early next year, taking the publicly traded company off the market, according to a story published Tuesday in the Wall Street Journal.

Walgreens is in talks to sell itself to a private equity firm, The Wall Street Journal reported.Joe Raedle/Getty Images Walgreens is in talks to sell itself to private equity firm Sycamore Partners.

Walgreens nand Sycamore have been discussing a deal that ... according to its website – has long been eyed as a possible private-equity acquisition, though its size seemingly put it out of ...

US giant Walgreens Boots Alliance, which owns the chemists chain, is in talks about selling itself to private equity group Sycamore Partners. New York-listed Walgreens is valued at around £5billion.

The pharmacy giant is in talks to sell itself to private equity firm Sycamore Partners in a deal that could close early next year, The Wall Street Journal reported Tuesday. Following the report ...